1. Home
  2. IFF vs ILMN Comparison

IFF vs ILMN Comparison

Compare IFF & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International Flavors & Fragrances Inc.

IFF

International Flavors & Fragrances Inc.

HOLD

Current Price

$83.61

Market Cap

20.0B

Sector

Industrials

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$206.45

Market Cap

32.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IFF
ILMN
Founded
1833
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.0B
32.3B
IPO Year
2010
2000

Fundamental Metrics

Financial Performance
Metric
IFF
ILMN
Price
$83.61
$206.45
Analyst Decision
Buy
Hold
Analyst Count
12
17
Target Price
$89.09
$124.24
AVG Volume (30 Days)
1.3M
1.6M
Earning Date
05-05-2026
04-30-2026
Dividend Yield
2.32%
N/A
EPS Growth
N/A
170.87
EPS
0.85
2.22
Revenue
N/A
$4,343,000,000.00
Revenue This Year
N/A
$6.47
Revenue Next Year
$3.11
$5.58
P/E Ratio
$99.19
$92.34
Revenue Growth
N/A
N/A
52 Week Low
$59.14
$88.00
52 Week High
$89.32
$231.81

Technical Indicators

Market Signals
Indicator
IFF
ILMN
Relative Strength Index (RSI) 49.01 46.54
Support Level $80.87 $182.76
Resistance Level $88.98 $207.00
Average True Range (ATR) 1.61 8.24
MACD -0.45 -2.16
Stochastic Oscillator 24.65 7.22

Price Performance

Historical Comparison
IFF
ILMN

About IFF International Flavors & Fragrances Inc.

International Flavors & Fragrances is the largest specialty ingredients producer globally. It sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations and partners with customers to deliver custom solutions. Through its taste and scent segments, which each generate around 25% of profits, IFF is a leading flavor and fragrance producer. The health and biosciences business, which generates 30% of profits, is a global leader in probiotics and enzymes. The remaining profits come from the food ingredients business, which sells texturants, plant-based proteins, and other ingredients, though IFF plans to divest it in a deal expected to close in 2027.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: